PTN

Palatin Technologies, Inc.

2.06 USD
+0.02 (+0.98%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Palatin Technologies, Inc. stock is up 19.77% since 30 days ago. The next earnings date is Sep 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 26 May’s closed higher than April. 100% of analysts rate it a buy.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the. treatment of premenopausal women with hypoactive sexual desire disorder.

  • HC Wainwright & Co.
    Wed May 15, 14:01
    buy
    confirm
  • HC Wainwright & Co.
    Wed May 8, 15:26
    buy
    confirm
  • HC Wainwright & Co.
    Thu May 2, 13:23
    buy
    confirm